David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.43% |
| 2 | Technology | 13.54% |
| 3 | Consumer Discretionary | 9.06% |
| 4 | Financials | 8.31% |
| 5 | Healthcare | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Afya
AFYA
$1.27B
| $1.07M | ﹤0.01% |
+74,424
| New | +$1.02M |
|
3702
Core Laboratories
CLB
$564M
| $1.07M | ﹤0.01% |
33,734
-25,433
| -43% | -$713K |
|
3703
Wheels Up
UP
$180M
| $1.07M | ﹤0.01% |
+1,714
| New | +$1.24M |
|
|
CORS
3704
DELISTED
Corsair Partnering Corporation
CORS
| $1.06M | ﹤0.01% |
109,664
+10,302
| +10% | +$99.6K |
|
3705
Dine Brands
DIN
$422M
| $1.06M | ﹤0.01% |
13,656
-3,061
| -18% | -$228K |
|
3706
Aldeyra Therapeutics
ALDX
$92.9M
| $1.06M | ﹤0.01% |
239,158
+202,930
| +560% | +$808K |
|
|
DHC
3707
Diversified Healthcare Trust
DHC
$1.9B
| $1.06M | ﹤0.01% |
332,063
+163,958
| +98% | +$501K |
|
3708
Coca-Cola Consolidated
COKE
$13B
| $1.06M | ﹤0.01% |
21,340
+17,320
| +431% | +$933K |
|
3709
Amneal Pharmaceuticals
AMRX
$6.27B
| $1.06M | ﹤0.01% |
253,999
+95,977
| +61% | +$425K |
|
3710
American Well
AMWL
$200M
| $1.06M | ﹤0.01% |
+12,581
| New | +$1.06M |
|
|
LIBYU
3711
DELISTED
Liberty Resources Acquisition Corp. Unit
LIBYU
| $1.06M | ﹤0.01% |
100,000
-200,000
| -67% | -$2.03M |
|
3712
GoodRx Holdings
GDRX
$1.2B
| $1.06M | ﹤0.01% |
54,681
+41,768
| +323% | +$958K |
|
|
NSA
3713
DELISTED
National Storage Affiliates Trust
NSA
| $1.06M | ﹤0.01% |
16,840
-6,296
| -27% | -$387K |
|
3714
Solid Power Inc Warrant
SLDPW
$5.84M
| $1.06M | ﹤0.01% |
444,121
+138,230
| +45% | +$273K |
|
3715
Zura Bio
ZURA
$561M
| $1.06M | ﹤0.01% |
106,597
+18,000
| +20% | +$177K |
|
3716
Blink Charging
BLNK
$83.5M
| $1.05M | ﹤0.01% |
39,883
-72,264
| -64% | -$1.7M |
|
3717
Sally Beauty Holdings
SBH
$1.54B
| $1.05M | ﹤0.01% |
67,469
+48,152
| +249% | +$834K |
|
3718
Ducommun
DCO
$2.78B
| $1.05M | ﹤0.01% |
20,083
+3,416
| +20% | +$163K |
|
3719
Goldgroup Mining
GORO
$511M
| $1.05M | ﹤0.01% |
469,768
+81,811
| +21% | +$152K |
|
|
BIG
3720
PUT
DELISTED
Big Lots, Inc.
BIG
| $1.05M | ﹤0.01% |
30,400
+9,000
| +42% | +$354K |
|
3721
Axcelis
ACLS
$3.78B
| $1.05M | ﹤0.01% |
+13,914
| New | +$950K |
|
|
AMED
3722
PUT
DELISTED
Amedisys
AMED
| $1.05M | ﹤0.01% |
6,100
-50,000
| -89% | -$7.47M |
|
3723
CRA International
CRAI
$1.08B
| $1.05M | ﹤0.01% |
12,442
-4,667
| -27% | -$409K |
|
3724
Fulton Financial
FULT
$4.53B
| $1.05M | ﹤0.01% |
63,045
-136,479
| -68% | -$2.44M |
|
3725
Syntec Optics
OPTX
$352M
| $1.05M | ﹤0.01% |
+105,300
| New | +$1.05M |
|
Similar funds
David Shaw's Q1 2022 Portfolio in Review
As of Q1 2022, David Shaw held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
David Shaw withdrew a net $10.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 42% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Cenovus Energy worth $141M.
- David Shaw's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- David Shaw added most to Starbucks in Q1 2022, an estimated $384M increase.
- David Shaw's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- David Shaw's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- David Shaw opened 934 new positions and closed 805 in Q1 2022.
- David Shaw's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.